Technical Analysis for BIO.B - Bio-Rad Laboratories, Inc. Class B
|Grade||Last Price||% Change||$ Change|
BIO.B closed unchanged on Friday, January 13, 2017, on 8 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Trend Table & Recent Alerts
|See historical BIO.B trend table...|
|Date||Alert Name||Type||% Chg|
|Jan 13||Calm After Storm||Range Contraction||0.00%|
|Jan 13||Boomer Buy Setup||Bullish Swing Setup||0.00%|
|Jan 13||Jack-in-the-Box Bullish||Bullish Swing Setup||0.00%|
|Jan 13||Expansion Breakout||Bullish Swing Setup||0.00%|
|Jan 13||Reversal New Highs Setup||Bullish Swing Setup||0.00%|
|Jan 13||Narrow Range Bar||Range Contraction||0.00%|
|Jan 12||Calm After Storm||Range Contraction||0.00%|
|Jan 12||Jack-in-the-Box Bullish||Bullish Swing Setup||0.00%|
|Jan 12||Expansion Breakout||Bullish Swing Setup||0.00%|
|Jan 12||Reversal New Highs Setup||Bullish Swing Setup||0.00%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
- Earnings date: 2016-01-01
Bio-Rad Laboratories, Inc. manufactures and supplies products and systems used to separate complex chemical and biological materials, as well as to identify, analyze, and purify their components for life science research, healthcare, analytical chemistry, and other markets. The company operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls that serve clinical laboratories in the diagnostics market. Its products address specific niches within the in vitro diagnostics (IVD) test market. This segment sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force and a service network worldwide. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Is BIO.B a Buy, Sell or Hold?
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more BIO.B news...
|52 Week High||188.0|
|52 Week Low||124.5|
|200-Day Moving Average||152.92|
|50-Day Moving Average||172.55|
|20-Day Moving Average||181.79|
|10-Day Moving Average||184.61|
|Average True Range||0.92|
|Chandelier Exit (Long, 3 ATRs)||185.24|
|Chandelier Exit (Short, 3 ATRs)||179.26|
|Upper Bollinger Band||189.54|
|Lower Bollinger Band||174.04|
|Percent B (%b)||0.9|